Performance of Survivin mRNA as a Biomarker for Bladder Cancer in the Prospective Study UroScreen.

MLA

Johnen, Georg, et al. “Performance of Survivin MRNA as a Biomarker for Bladder Cancer in the Prospective Study UroScreen.” PLoS ONE, vol. 7, no. 4, Apr. 2012, pp. 1–10. EBSCOhost, https://doi.org/10.1371/journal.pone.0035363.

APA

Johnen, G., Gawrych, K., Bontrup, H., Pesch, B., Taeger, D., Banek, S., Kluckert, M., Wellhäußer, H., Eberle, F., Nasterlack, M., Leng, G., Stenzl, A., & Brüning, T. (2012). Performance of Survivin mRNA as a Biomarker for Bladder Cancer in the Prospective Study UroScreen. PLoS ONE, 7(4), 1–10. https://doi.org/10.1371/journal.pone.0035363

Chicago

Johnen, Georg, Katarzyna Gawrych, Heike Bontrup, Beate Pesch, Dirk Taeger, Séverine Banek, Matthias Kluckert, et al. 2012. “Performance of Survivin MRNA as a Biomarker for Bladder Cancer in the Prospective Study UroScreen.” PLoS ONE 7 (4): 1–10. doi:10.1371/journal.pone.0035363.